Hu B, Guo H, Zhou P, Shi ZL. Characteristics of SARS-CoV-2 and COVID-19. Nat Rev Microbiol. 2021;19(141):54.
Attaway AH, Scheraga RG, Bhimraj A, Biehl M, Hatipoğ LuU. Severe covid-19 pneumonia: pathogenesis and clinical management. BMJ. 2021. https://doi.org/10.1136/bmj.n436.
Gupta A, Madhavan MV, Sehgal K, Nair N, Mahajan S, Sehrawat TS, et al. Extrapulmonary manifestations of COVID-19. Nat Med. 2020. https://doi.org/10.1038/s41591-020-0968-3.
Article PubMed PubMed Central Google Scholar
Williamson EJ, Walker AJ, Bhaskaran K, Bacon S, Bates C, Morton CE, et al. Factors associated with COVID-19-related death using OpenSAFELY. Nature. 2020;584:430–6.
CAS PubMed PubMed Central Google Scholar
Dessie ZG, Zewotir T. Mortality-related risk factors of COVID-19: a systematic review and meta-analysis of 42 studies and 423,117 patients. BMC Infect Dis. 2021. https://doi.org/10.1186/s12879-021-06536-3.
Article PubMed PubMed Central Google Scholar
Nishiga M, Wang DW, Han Y, Lewis DB, Wu JC. COVID-19 and cardiovascular disease: from basic mechanisms to clinical perspectives. Nat Rev Cardiol. 2020;17:543–58.
CAS PubMed PubMed Central Google Scholar
Stefan N, Birkenfeld AL, Schulze MB. Global pandemics interconnected - obesityimpaired metabolic health and COVID-19. Nat Rev Endocrinol. 2021;17:135–49.
Belsky JA, Tullius BP, Lamb MG, Sayegh R, Stanek JR, Auletta JJ. COVID-19 in immunocompromised patients: a systematic review of cancerhematopoietic cell and solid organ transplant patients. J Infect. 2021;82:329–38. https://doi.org/10.1016/j.jinf.2021.01.022.
Article CAS PubMed PubMed Central Google Scholar
V’kovski P, Kratzel A, Steiner S, Stalder H, Thiel V. Coronavirus biology and replication: implications for SARS-CoV-2. Nat Rev Microbiol. 2021;19:155–70.
Ayres JS. A metabolic handbook for the COVID-19 pandemic. Nat Metab. 2020;2:572–85.
CAS PubMed PubMed Central Google Scholar
Flerlage T, Boyd DF, Meliopoulos V, Thomas PG, Schultz-Cherry S. Influenza virus and SARS-CoV-2: pathogenesis and host responses in the respiratory tract. Nat Rev. 2021;19:425–41.
Shen B, Yi X, Sun Y, Bi X, Du J, Zhang C, et al. Proteomic and Metabolomic Characterization of COVID-19 Patient Sera. Cell. 2020;182:59-72.e15.
CAS PubMed PubMed Central Google Scholar
Messner CB, Demichev V, Wendisch D, Michalick L, White M, Freiwald A, et al. Ultra-high-throughput clinical proteomics reveals classifiers of COVID-19 infection. Cell Syst. 2020;11:11-24.e4.
CAS PubMed PubMed Central Google Scholar
Shu T, Ning W, Wu D, Xu J, Han Q, Huang M, et al. Plasma Proteomics identify biomarkers and pathogenesis of COVID-19. Immunity. 2020;53:1108-1122.e5.
CAS PubMed PubMed Central Google Scholar
Su Y, Chen D, Yuan D, Lausted C, Choi J, Dai CL, et al. Multi-omics resolves a sharp disease-state shift between mild and moderate COVID-19. Cell. 2020;183:1479-1495.e20.
CAS PubMed PubMed Central Google Scholar
Overmyer KA, Shishkova E, Miller IJ, Balnis J, Bernstein MN, Peters-Clarke TM, et al. Large-scale multi-omic analysis of COVID-19 severity. Cell Syst. 2021;12:23-40.e7.
Schimke LF, Marques AHC, Baiocchi GC, de Souza Prado CA, Fonseca DLM, Freire PP, et al. Severe COVID-19 shares a common neutrophil activation signature with other acute inflammatory states. Cells. 2022;11:847.
CAS PubMed PubMed Central Google Scholar
Vora SM, Lieberman J, Wu H. Inflammasome activation at the crux of severe COVID-19. Nat Rev Immunol. 2021;21:694–703.
PubMed PubMed Central Google Scholar
Chen Z, Wherry EJ. T cell responses in patients with COVID-19. Nat Rev. 2020;20:529–36.
Song JW, Zhang C, Fan X, Meng FP, Xu Z, Xia P, et al. Immunological and inflammatory profiles in mild and severe cases of COVID-19. Nat Commun. 2020;11:3410.
CAS PubMed PubMed Central Google Scholar
De Biasi S, Meschiari M, Gibellini L, Bellinazzi C, Borella R, Fidanza L, et al. Marked T cell activationsenescenceexhaustion and skewing towards TH17 in patients with COVID-19 pneumonia. Nat Commun. 2020;11:3434.
PubMed PubMed Central Google Scholar
Rydyznski MC, Ramirez SI, Dan JM, Grifoni A, Hastie KM, Weiskopf D, et al. Antigen-specific adaptive immunity to SARS-CoV-2 in acute COVID-19 and associations with age and disease severity. Cell. 2020;183:996-1012.e19.
Berlin DA, Gulick RM, Martinez FJ. Severe Covid-19. N Engl J Med. 2020;383:2451–60.
Ackermann M, Verleden SE, Kuehnel M, Haverich A, Welte T, Laenger F, et al. Pulmonary Vascular EndothelialitisThrombosisand Angiogenesis in Covid-19 HHS Public Access. N Engl J Med. 2020;383:120–8.
CAS PubMed PubMed Central Google Scholar
Chandramouli K, Qian P-Y. Proteomics: challengestechniques and possibilities to overcome biological sample complexity. Hum Genom Proteom. 2009. https://doi.org/10.4061/2009/239204.
Ciccosanti F, Di Rienzo M, Romagnoli A, Colavita F, Refolo G, Castilletti C, et al. Proteomic analysis identifies the RNA helicase DDX3X as a host target against SARS-CoV-2 infection. Antiviral Res. 2021;190:105064.
CAS PubMed PubMed Central Google Scholar
Tyanova S, Temu T, Carlson A, Sinitcyn P, Mann M, Cox J. Visualization of LC-MS/MS proteomics data in MaxQuant. Proteomics. 2015;15:1453–6.
CAS PubMed PubMed Central Google Scholar
Tyanova S, Temu T, Sinitcyn P, Carlson A, Hein MY, Geiger T, et al. The perseus computational platform for comprehensive analysis of (prote)omics data. Nat Methods. 2016;13:731–40.
Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003;13:2498–504.
CAS PubMed PubMed Central Google Scholar
Lee KJ, Carlin JB. Multiple imputation for missing data: fully conditional specification versus multivariate normal imputation. Am J Epidemiol. 2010;171:624–32.
Carbon S, Douglass E, Dunn N, Good B, Harris NL, Lewis SE, et al. The gene ontology resource: 20 years and still going strong. Nucleic Acids Res. 2019;47:D330-8.
Martin TR, Wurfel MM, Zanoni I, Ulevitch R. Targeting innate immunity by blocking CD14: Novel approach to control inflammation and organ dysfunction in COVID-19 illness. EBioMedicine. 2020;57:102836.
PubMed PubMed Central Google Scholar
Anas A, van der Poll T, Vos AF. Role of CD14 in lung inflammation and infection. Crit Care. 2010;14:209.
PubMed PubMed Central Google Scholar
DeRoo EP, Wrobleski SK, Shea EM, Al-Khalil RK, Hawley AE, Henke PK, et al. The role of galectin-3 and galectin-3-binding protein in venous thrombosis. Blood. 2015;125:1813–21.
CAS PubMed PubMed Central Google Scholar
Malaquias MAS, Gadotti AC, da Motta-Junior JS, Martins APC, Azevedo MLV, Benevides APK, et al. The role of the lectin pathway of the complement system in SARS-CoV-2 lung injury. Transl Res. 2021;231:55–63.
Das N, Schmidt TA, Krawetz RJ, Dufour A. Proteoglycan 4: from mere lubricant to regulator of tissue homeostasis and inflammation: does proteoglycan 4 have the ability to buffer the inflammatory response? Bioessays. 2019. https://doi.org/10.1002/bies.201800166.
Ahlfeld SK, Wang J, Gao Y, Snider P, Conway SJ. Initial suppression of transforming growth factor-β signaling and loss of TGFBI causes early alveolar structural defects resulting in bronchopulmonary dysplasia. Am J Pathol. 2016;186:777–93.
CAS PubMed PubMed Central Google Scholar
Anderson DH, Radeke MJ, Gallo NB, Chapin EA, Johnson PT, Curletti CR, et al. The pivotal role of the complement system in aging and age-related macular degeneration: hypothesis re-visited. Prog Retin Eye Res. 2010;29:95–112.
Kreus M, Lehtonen S, Skarp S, Kaarteenaho R. Extracellular matrix proteins produced by stromal cells in idiopathic pulmonary fibrosis and lung adenocarcinoma. PLoS One. 2021. https://doi.org/10.1371/journal.pone.0250109.
Article PubMed PubMed Central Google Scholar
Niu L, Geyer PE, Wewer ANJ, Gluud LL, Santos A, Doll S, et al. Plasma proteome profiling discovers novel proteins associated with non-alcoholic fatty liver disease. Mol Syst. 2019. https://doi.org/10.15252/msb.20188793.
Schwanekamp JA, Lorts A, Sargent MA, York AJ, Grimes KM, Fischesser DM, et al. TGFBI functions similar to periostin but is uniquely dispensable during cardiac injury. PLoS One. 2017. https://doi.org/10.1371/journal.pone.0181945.
Article PubMed PubMed Central Google Scholar
Xu F, Tanabe N, Vasilescu DM, McDonough JE, Coxson HC, Ikezoe K, et al. The transition from normal lung anatomy to minimal and established fibrosis in idiopathic pulmonary fibrosis (IPF). EbioMedicine. 2021.
留言 (0)